arrow
J

Jing Quan Lim

lymphoma translational research laboratory
H指数:26
被引数:3,995

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multimodal spatial profiling reveals distinct myeloid-defined ENKTL subgroups and tumor-myeloid cooperativity within prognostic inflammatory niche

多模态空间分析揭示髓系定义的ENKTL亚组及其在预后炎性微环境中的肿瘤-髓系协同作用

Leukemia
IF13.4
2026-08-240
OAAI
Efficacy of combined CD38 and PD-1 inhibition with isatuximab and cemiplimab for relapsed/refractory NK/T-cell lymphoma

CD38和PD-1联合抑制(使用isatuximab和cemiplimab)对复发/难治性NK/T细胞淋巴瘤的疗效

Blood
IF23.1
2025-03-130
PRE
Therapeutic Repurposing of Brincidofovir in Non-Hodgkin Lymphoma- Potential Synergy with Immune Checkpoint Blockade

非霍奇金淋巴瘤中布马那韦的治疗重定位——与免疫检查点阻断的潜在协同作用

BLOOD
IF23.1
2024-11-050
PRE
Potent anti-proliferative activity of brincidofovir in Diffuse Large B-cell Lymphoma with overexpression of transcriptional repressor TLE1
2024-03-220
PRE
Single-Cell Analysis Reveals Malignant Cells Reshape the Cellular Landscape and Foster an Immunosuppressive Microenvironment of Extranodal NK/T-Cell Lymphoma

单细胞分析揭示恶性细胞重塑细胞景观并促进结外NK/T细胞淋巴瘤的免疫抑制微环境

2023-11-104
OA
Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma

超级增强子驱动的TOX2介导自然杀伤/T细胞淋巴瘤的肿瘤发生

2023-04-1015
OAAI
Single cell landscape of multicentric Castleman disease in identical twins
2023-04-040
PRE
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort
2022-07-056
OAAI
CREBBP cooperates with the cell cycle machinery to attenuate chidamide sensitivity in relapsed/refractory diffuse large B-cell lymphoma
2021-11-0113
OAAI